• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

认知正常个体对血浆和脑脊液中β淀粉样蛋白的耐受性:两项队列研究的结果

Resilience to Plasma and Cerebrospinal Fluid Amyloid-β in Cognitively Normal Individuals: Findings From Two Cohort Studies.

作者信息

Lin Li, Sun Yu, Wang Xiaoqi, Su Li, Wang Xiaoni, Han Ying

机构信息

Department of Neurology, XuanWu Hospital of Capital Medical University, Beijing, China.

Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom.

出版信息

Front Aging Neurosci. 2021 Feb 24;13:610755. doi: 10.3389/fnagi.2021.610755. eCollection 2021.

DOI:10.3389/fnagi.2021.610755
PMID:33716709
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7943465/
Abstract

To define resilience metrics for cognitive decline based on plasma and cerebrospinal fluid (CSF) amyloid-β (Aβ) and examine the demographic, genetic, and neuroimaging factors associated with interindividual differences among metrics of resilience and to demonstrate the ability of such metrics to predict the diagnostic conversion to mild cognitive impairment (MCI). In this study, cognitively normal (CN) participants with Aβ-positive were included from the Sino Longitudinal Study on Cognitive Decline (SILCODE, = 100) and Alzheimer's Disease Neuroimaging Initiative (ADNI, = 144). Using a latent variable model of data, metrics of resilience [brain resilience (BR), cognitive resilience (CR), and global resilience (GR)] were defined based on the plasma Aβ and CSF Aβ. Linear regression analyses were applied to investigate the association between characteristics of individuals (age, sex, educational level, genetic, and neuroimaging factors) and their resilience. The plausibility of these metrics was tested using linear mixed-effects models and Cox regression models in longitudinal analyses. We also compared the effectiveness of these metrics with conventional metrics in predicting the clinical progression. Although individuals in the ADNI cohort were older (74.68 [5.65] vs. 65.38 [4.66], < 0.001) and had higher educational levels (16.3 [2.6] vs. 12.6 [2.8], < 0.001) than those in the SILCODE cohort, similar loadings between resilience and its indicators were found within both models. BR and GR were mainly associated with age, women, and brain volume in both cohorts. Prediction models showed that higher CR and GR were related to better cognitive performance, and specifically, all types of resilience to CSF Aβ could predict longitudinal cognitive decline. Different phenotypes of resilience depending on cognition and brain volumes were associated with different factors. Such comprehensive resilience provided insight into the mechanisms of susceptibility for Alzheimer's disease (AD) at the individual level, and interindividual differences in resilience had the potential to predict the disease progression in CN people.

摘要

基于血浆和脑脊液(CSF)淀粉样蛋白-β(Aβ)定义认知衰退的恢复力指标,研究与恢复力指标个体差异相关的人口统计学、遗传学和神经影像学因素,并证明这些指标预测向轻度认知障碍(MCI)诊断转化的能力。在本研究中,从中国认知衰退纵向研究(SILCODE,n = 100)和阿尔茨海默病神经影像学倡议(ADNI,n = 144)中纳入Aβ阳性的认知正常(CN)参与者。使用数据的潜在变量模型,基于血浆Aβ和脑脊液Aβ定义恢复力指标[脑恢复力(BR)、认知恢复力(CR)和整体恢复力(GR)]。应用线性回归分析研究个体特征(年龄、性别、教育水平、遗传学和神经影像学因素)与其恢复力之间的关联。在纵向分析中使用线性混合效应模型和Cox回归模型测试这些指标的合理性。我们还比较了这些指标与传统指标在预测临床进展方面的有效性。尽管ADNI队列中的个体比SILCODE队列中的个体年龄更大(74.68 [5.65] 对65.38 [4.66],P < 0.001)且教育水平更高(16.3 [2.6] 对12.6 [2.8],P < 0.001),但在两个模型中均发现恢复力与其指标之间的负荷相似。在两个队列中,BR和GR主要与年龄、女性和脑容量相关。预测模型表明,较高的CR和GR与更好的认知表现相关,具体而言,对脑脊液Aβ的所有类型恢复力都可以预测纵向认知衰退。根据认知和脑容量不同的恢复力表型与不同因素相关。这种综合恢复力在个体水平上为阿尔茨海默病(AD)易感性机制提供了见解,恢复力的个体差异有可能预测CN人群的疾病进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2668/7943465/c50ad74db047/fnagi-13-610755-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2668/7943465/645a06572e13/fnagi-13-610755-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2668/7943465/4876fd48da6a/fnagi-13-610755-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2668/7943465/c50ad74db047/fnagi-13-610755-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2668/7943465/645a06572e13/fnagi-13-610755-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2668/7943465/4876fd48da6a/fnagi-13-610755-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2668/7943465/c50ad74db047/fnagi-13-610755-g0003.jpg

相似文献

1
Resilience to Plasma and Cerebrospinal Fluid Amyloid-β in Cognitively Normal Individuals: Findings From Two Cohort Studies.认知正常个体对血浆和脑脊液中β淀粉样蛋白的耐受性:两项队列研究的结果
Front Aging Neurosci. 2021 Feb 24;13:610755. doi: 10.3389/fnagi.2021.610755. eCollection 2021.
2
ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.载脂蛋白E4对轻度认知障碍和阿尔茨海默病自动诊断分类器的影响。
Neuroimage Clin. 2014 Jan 4;4:461-72. doi: 10.1016/j.nicl.2013.12.012. eCollection 2014.
3
Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease.评估与阿尔茨海默病患者病理性 Tau 相关的脑储备和认知储备的人口统计学、遗传学和影像学变量。
JAMA Neurol. 2020 May 1;77(5):632-642. doi: 10.1001/jamaneurol.2019.5154.
4
The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies.认知弹性的代谢性大脑特征:超越阿尔茨海默病病理学。
Brain. 2019 Apr 1;142(4):1134-1147. doi: 10.1093/brain/awz037.
5
Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.脑脊液突触体相关蛋白 25 是轻度认知障碍和阿尔茨海默病中突触退化的关键因素。
Alzheimers Res Ther. 2018 Aug 16;10(1):80. doi: 10.1186/s13195-018-0407-6.
6
Plasma p-tau181 Level Predicts Neurodegeneration and Progression to Alzheimer's Dementia: A Longitudinal Study.血浆p-tau181水平可预测神经退行性变及向阿尔茨海默病痴呆的进展:一项纵向研究。
Front Neurol. 2021 Sep 7;12:695696. doi: 10.3389/fneur.2021.695696. eCollection 2021.
7
Baseline structural MRI and plasma biomarkers predict longitudinal structural atrophy and cognitive decline in early Alzheimer's disease.基线结构 MRI 和血浆生物标志物可预测早期阿尔茨海默病的纵向结构萎缩和认知能力下降。
Alzheimers Res Ther. 2023 Apr 11;15(1):79. doi: 10.1186/s13195-023-01210-z.
8
Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers.使用血浆生物标志物预测临床前阿尔茨海默病的纵向认知下降。
JAMA Neurol. 2023 Apr 1;80(4):360-369. doi: 10.1001/jamaneurol.2022.5272.
9
Plasma adiponectin levels predict cognitive decline and cortical thinning in mild cognitive impairment with beta-amyloid pathology.血浆脂联素水平可预测伴有β-淀粉样蛋白病理的轻度认知障碍患者的认知下降和皮质变薄。
Alzheimers Res Ther. 2022 Nov 4;14(1):165. doi: 10.1186/s13195-022-01107-3.
10
Amyloid-β Positivity Predicts Cognitive Decline but Cognition Predicts Progression to Amyloid-β Positivity.淀粉样蛋白-β 阳性预测认知能力下降,但认知能力预测向淀粉样蛋白-β 阳性进展。
Biol Psychiatry. 2020 May 1;87(9):819-828. doi: 10.1016/j.biopsych.2019.12.021. Epub 2020 Jan 7.

引用本文的文献

1
The impact of interactions between heavy metals and smoking exposures on the formation of oral microbial communities.重金属与吸烟暴露之间的相互作用对口腔微生物群落形成的影响。
Front Microbiol. 2024 Dec 18;15:1502812. doi: 10.3389/fmicb.2024.1502812. eCollection 2024.
2
Relationship Between Excessive Daytime Sleepiness and Caudate Nucleus Volume in Patients with Subjective Cognitive Decline: A Study from the SILCODE Using the Volbrain.主观认知衰退患者日间过度嗜睡与尾状核体积的关系:一项来自SILCODE使用Volbrain的研究
J Alzheimers Dis Rep. 2024 Jun 18;8(1):935-944. doi: 10.3233/ADR-230101. eCollection 2024.
3

本文引用的文献

1
Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease.评估与阿尔茨海默病患者病理性 Tau 相关的脑储备和认知储备的人口统计学、遗传学和影像学变量。
JAMA Neurol. 2020 May 1;77(5):632-642. doi: 10.1001/jamaneurol.2019.5154.
2
Brain imaging measurements of fibrillar amyloid-β burden, paired helical filament tau burden, and atrophy in cognitively unimpaired persons with two, one, and no copies of the APOE ε4 allele.在认知正常的个体中,具有两个、一个和没有 APOE ε4 等位基因拷贝的情况下,对纤维状淀粉样-β负担、配对螺旋丝 tau 负担和萎缩进行脑成像测量。
Alzheimers Dement. 2020 Apr;16(4):598-609. doi: 10.1016/j.jalz.2019.08.195. Epub 2020 Jan 16.
3
The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022.
阿尔茨海默病神经影像学倡议在阿尔茨海默病治疗时代:对 2021 年至 2022 年 ADNI 研究的回顾。
Alzheimers Dement. 2024 Jan;20(1):652-694. doi: 10.1002/alz.13449. Epub 2023 Sep 12.
4
Translational approaches to understanding resilience to Alzheimer's disease.理解阿尔茨海默病抗逆力的转化方法。
Trends Neurosci. 2022 May;45(5):369-383. doi: 10.1016/j.tins.2022.02.005. Epub 2022 Mar 17.
5
Oral microbiota in human systematic diseases.口腔微生物群与人类系统性疾病。
Int J Oral Sci. 2022 Mar 2;14(1):14. doi: 10.1038/s41368-022-00163-7.
Reserve in Alzheimer's disease: update on the concept, functional mechanisms and sex differences.阿尔茨海默病中的储备:概念、功能机制和性别差异的更新。
Curr Opin Psychiatry. 2020 Mar;33(2):178-184. doi: 10.1097/YCO.0000000000000574.
4
Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease.超敏检测血浆淀粉样蛋白-β作为阿尔茨海默病风险认知正常老年人的生物标志物。
J Alzheimers Dis. 2019;71(3):775-783. doi: 10.3233/JAD-190533.
5
Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition.血浆β淀粉样蛋白水平与脑淀粉样蛋白和tau蛋白沉积有关。
Alzheimers Dement (Amst). 2019 Jul 26;11:510-519. doi: 10.1016/j.dadm.2019.05.007. eCollection 2019 Dec.
6
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis.高精度血浆β-淀粉样蛋白 42/40 可预测当前和未来的脑淀粉样变。
Neurology. 2019 Oct 22;93(17):e1647-e1659. doi: 10.1212/WNL.0000000000008081. Epub 2019 Aug 1.
7
Sino Longitudinal Study on Cognitive Decline (SILCODE): protocol for a Chinese longitudinal observational study to develop risk prediction models of conversion to mild cognitive impairment in individuals with subjective cognitive decline.中国认知衰退纵向研究(SILCODE):一项旨在开发主观认知下降人群向轻度认知障碍转化风险预测模型的中国纵向观察研究方案。
BMJ Open. 2019 Jul 26;9(7):e028188. doi: 10.1136/bmjopen-2018-028188.
8
Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging-Alzheimer's Association Research Framework.使用美国国立衰老研究所-阿尔茨海默病协会研究框架对生物学定义与临床定义的阿尔茨海默病谱系实体的患病率进行研究。
JAMA Neurol. 2019 Oct 1;76(10):1174-1183. doi: 10.1001/jamaneurol.2019.1971.
9
Cognitive reserve and clinical progression in Alzheimer disease: A paradoxical relationship.认知储备与阿尔茨海默病的临床进展:一种矛盾的关系。
Neurology. 2019 Jul 23;93(4):e334-e346. doi: 10.1212/WNL.0000000000007821. Epub 2019 Jul 2.
10
Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease.血浆淀粉样蛋白β 40/42 比值可预测阿尔茨海默病高危认知正常个体的脑淀粉样变。
Alzheimers Dement. 2019 Jun;15(6):764-775. doi: 10.1016/j.jalz.2019.03.009. Epub 2019 May 18.